File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/dneu.22644
- Scopus: eid_2-s2.0-85055290276
- PMID: 30304570
- WOS: WOS:000456599600003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Application of Human‐Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders
Title | Application of Human‐Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders |
---|---|
Authors | |
Keywords | Synaptognenesis Human‐induced pluripotent stem cells (hiPSCs) autism spectrum disorder (ASD) schizophrenia (SCZ) |
Issue Date | 2019 |
Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/31737 |
Citation | Developmental Neurobiology, 2019, v. 79 n. 1, p. 20-35 How to Cite? |
Abstract | Synapses are the basic structural and functional units for information processing and storage in the brain. Their diverse properties and functions ultimately underlie the complexity of human behavior. Proper development and maintenance of synapses are essential for normal functioning of the nervous system. Disruption in synaptogenesis and the consequent alteration in synaptic function have been strongly implicated to cause neurodevelopmental disorders such as autism spectrum disorders (ASDs) and schizophrenia (SCZ). The introduction of human-induced pluripotent stem cells (hiPSCs) provides a new path to elucidate disease mechanisms and potential therapies. In this review, we will discuss the advantages and limitations of using hiPSC-derived neurons to study synaptic disorders. Many mutations in genes encoding for proteins that regulate synaptogenesis have been identified in patients with ASDs and SCZ. We use Methyl-CpG binding protein 2 (MECP2), SH3 and multiple ankyrin repeat domains 3 (SHANK3) and Disrupted in schizophrenia 1 (DISC1) as examples to illustrate the promise of using hiPSCs as cellular models to elucidate the mechanisms underlying disease-related synaptopathy. |
Description | Link to Free access |
Persistent Identifier | http://hdl.handle.net/10722/272725 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 1.259 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shen, X | - |
dc.contributor.author | Yeung, HT | - |
dc.contributor.author | Lai, KO | - |
dc.date.accessioned | 2019-08-06T09:15:23Z | - |
dc.date.available | 2019-08-06T09:15:23Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Developmental Neurobiology, 2019, v. 79 n. 1, p. 20-35 | - |
dc.identifier.issn | 1932-8451 | - |
dc.identifier.uri | http://hdl.handle.net/10722/272725 | - |
dc.description | Link to Free access | - |
dc.description.abstract | Synapses are the basic structural and functional units for information processing and storage in the brain. Their diverse properties and functions ultimately underlie the complexity of human behavior. Proper development and maintenance of synapses are essential for normal functioning of the nervous system. Disruption in synaptogenesis and the consequent alteration in synaptic function have been strongly implicated to cause neurodevelopmental disorders such as autism spectrum disorders (ASDs) and schizophrenia (SCZ). The introduction of human-induced pluripotent stem cells (hiPSCs) provides a new path to elucidate disease mechanisms and potential therapies. In this review, we will discuss the advantages and limitations of using hiPSC-derived neurons to study synaptic disorders. Many mutations in genes encoding for proteins that regulate synaptogenesis have been identified in patients with ASDs and SCZ. We use Methyl-CpG binding protein 2 (MECP2), SH3 and multiple ankyrin repeat domains 3 (SHANK3) and Disrupted in schizophrenia 1 (DISC1) as examples to illustrate the promise of using hiPSCs as cellular models to elucidate the mechanisms underlying disease-related synaptopathy. | - |
dc.language | eng | - |
dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/31737 | - |
dc.relation.ispartof | Developmental Neurobiology | - |
dc.rights | This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. | - |
dc.subject | Synaptognenesis | - |
dc.subject | Human‐induced pluripotent stem cells (hiPSCs) | - |
dc.subject | autism spectrum disorder (ASD) | - |
dc.subject | schizophrenia (SCZ) | - |
dc.title | Application of Human‐Induced Pluripotent Stem Cells (hiPSCs) to Study Synaptopathy of Neurodevelopmental Disorders | - |
dc.type | Article | - |
dc.identifier.email | Shen, X: xtshen@hku.hk | - |
dc.identifier.email | Lai, KO: laiko@hku.hk | - |
dc.identifier.authority | Lai, KO=rp01891 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1002/dneu.22644 | - |
dc.identifier.pmid | 30304570 | - |
dc.identifier.scopus | eid_2-s2.0-85055290276 | - |
dc.identifier.hkuros | 299782 | - |
dc.identifier.volume | 79 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 20 | - |
dc.identifier.epage | 35 | - |
dc.identifier.isi | WOS:000456599600003 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1932-8451 | - |